| APHKX | FMIYX | APHKX / FMIYX | |
| Total Expense Ratio | 0.97 | 0.80 | 121% |
| Annual Report Gross Expense Ratio | 0.97 | 0.80 | 121% |
| Fund Existence | 20 years | 10 years | - |
| Gain YTD | 10.638 | 0.428 | 2,486% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 42.6B | 1.98B | 2,154% |
| Annual Yield % from dividends | 1.57 | 4.33 | 36% |
| Returns for 1 year | 16.49 | -2.84 | -580% |
| Returns for 3 years | 45.25 | 15.12 | 299% |
| Returns for 5 years | 36.62 | 18.19 | 201% |
| Returns for 10 years | 107.53 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLCH | 22.68 | 0.57 | +2.58% |
| Franklin FTSE China ETF | |||
| KMAR | 31.62 | 0.13 | +0.41% |
| Innovator U.S. Small Cp Pwr Buf ETF -Mar | |||
| FLQM | 56.80 | -0.25 | -0.44% |
| Franklin US Mid Cap Mltfctr Idx ETF | |||
| LRNZ | 63.53 | -0.50 | -0.78% |
| TrueShares Tech, AI and Deep Lrng ETF | |||
| THNR | 23.91 | -0.36 | -1.47% |
| Amplify Weight Loss Drug & Treatment ETF | |||